Form 4 for CYTK CYTOKINETICS INC
Accepted 2023-01-12 00:00:00 ET · period of report 2023-01-12 · accession 0001127602-23-001332 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-01-12 | 2023-01-12 | CYTK | Malik Fady Ibraham | EVP Research, Development | S - Sale | $40.47 | -4,000 | 156.6K | -2% | -$161.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-01-12 | S | D | 4,000 | $40.47 | 156,589 | D | — | — |